|
Michael L. Mead
Chairman (non-executive) since 2011; Director since March 2010
Held investment research and portfolio management positions from 1997 to his retirement in 2008 (Director - Global Equities from 2004 to 2008) with the Howard Hughes Medical Institute Investment Department, which manages the Institute's endowment.
|
|
David J. Christensen
Director since 2008
President, Chief Executive Officer and Chief Investment Officer since 2009; Vice President - Investments from 2007 to 2009; Vice President, Corporate Development of Gabriel Resources Ltd. 2006 to 2008; independent financial consultant from 2003 to 2006; Director of Fundamental Equity Research for Credit Suisse First Boston from 2002 to 2003; First Vice President, Global Coordinator of Mining Research at Merrill Lynch 1998 to 2001 and Precious Metals Analyst at Merrill Lynch from 1994 to 1998; Portfolio Manager of Franklin Gold Fund and Valuemark Precious Metals Funds for Franklin Templeton Group (a global investment management organization) from 1990 to 1994. Other directorships include the Denver Gold Group (a non-profit industry association).
|
|
Phillip Goldstein
Director since 2008
Self-employed investment advisor since 1992; principal of the general partner of six private investment partnerships in the Bulldog Investors group of funds. Other directorships include Brantley Capital Corporation, Mexico Equity and Income Fund and Special Opportunities Fund, Inc.
|
|
Andrew Pegge
Deputy Chairman (non-executive) since 2009; Director since 2008.
Director and Chief Executive Officer of Laxey Partners Limited (global active value fund manager) since 1999.
|
|
Robert A. Pilkington
Director since 2004 (ASA South Africa 1979–2005).
Investment banker and Managing Director of UBS Securities LLC and predecessor companies since 1985. Other directorships include Avocet Mining PLC (gold mining company).
|
